Next report date
Report period
Q1 2024
EPS estimate
1.36EUR
Revenue estimate
136.18 MEUR
1.33EUR
43.63 MEUR
513.50 MEUR
31.49 M
About Collegium Pharmaceutical, Inc.
Sector
CEO
Joseph J. Ciaffoni
Headquarters
Stoughton
Website
Employees (FY)
197
Founded
2002
Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 354 is 34.80 EUR — it has decreased by 0.57% in the past 24 hours. Watch COLLEGIUM PHARMACEUTICAL INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange COLLEGIUM PHARMACEUTICAL INC stocks are traded under the ticker 354.
COLLEGIUM PHARMACEUTICAL INC is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
354 stock is 1.15% volatile and has beta coefficient of 0.71. Track COLLEGIUM PHARMACEUTICAL INC stock price on the chart and check out the list of the most volatile stocks — is COLLEGIUM PHARMACEUTICAL INC there?
354 earnings for the last quarter are 1.27 EUR per share, whereas the estimation was 1.15 EUR resulting in a 10.00% surprise. The estimated earnings for the next quarter are 1.25 EUR per share. See more details about COLLEGIUM PHARMACEUTICAL INC earnings.
COLLEGIUM PHARMACEUTICAL INC revenue for the last quarter amounts to 129.33 M EUR despite the estimated figure of 129.86 M EUR. In the next quarter revenue is expected to reach 133.97 M EUR.
Yes, you can track COLLEGIUM PHARMACEUTICAL INC financials in yearly and quarterly reports right on TradingView.
354 stock has risen by 4.19% compared to the previous week, the month change is a 2.79% fall, over the last year COLLEGIUM PHARMACEUTICAL INC has showed a 74.00% increase.
354 net income for the last quarter is 28.94 M EUR, while the quarter before that showed 19.52 M EUR of net income which accounts for 48.25% change. Track more COLLEGIUM PHARMACEUTICAL INC financial stats to get the full picture.
Today COLLEGIUM PHARMACEUTICAL INC has the market capitalization of 1.12 B, it has increased by 1.51% over the last week.
No, 354 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 354 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade COLLEGIUM PHARMACEUTICAL INC stock right from TradingView charts — choose your broker and connect to your account.
As of May 6, 2024, the company has 197.00 employees. See our rating of the largest employees — is COLLEGIUM PHARMACEUTICAL INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So COLLEGIUM PHARMACEUTICAL INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating COLLEGIUM PHARMACEUTICAL INC stock shows the neutral signal. See more of COLLEGIUM PHARMACEUTICAL INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on COLLEGIUM PHARMACEUTICAL INC future price: according to them, 354 price has a max estimate of 37.71 EUR and a min estimate of 35.87 EUR. Watch 354 chart and read a more detailed COLLEGIUM PHARMACEUTICAL INC stock forecast: see what analysts think of COLLEGIUM PHARMACEUTICAL INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. COLLEGIUM PHARMACEUTICAL INC EBITDA is 293.96 M EUR, and current EBITDA margin is 57.29%. See more stats in COLLEGIUM PHARMACEUTICAL INC financial statements.